Thursday, June 2, 2005 Chair: Pascal Dohmen, MD - Charité, Humboldt University, Berlin, Germany Current Strategies in the Surgical Treatment of Active Endocarditis Alternative Stentless Bioprostheses in Active Endocarditis Factors Influencing the Results of Double Valve Surgery in Patients with Fulminant Endocarditis Pathophysiology of Xenograft Resistance to Infective Endocarditis and the Importance of Biomodification Clinical Experience with 100 No-React® Bioconduits Sponsored by: Shelhigh, Incorporated
Current Strategies in the Surgical Treatment of Active Endocarditis
12:00PM – 1:00PM, Marquis Ballroom C, 9th Floor, New York Marriott Marquis
Marko Turina, MD, PhD; Andreas Kuenzli, MD
University Hospital, Zurich, Switzerland
Pascal Dohmen, MD
Charité, Humboldt University, Berlin, Germany
Henryk Siniawski, MD, PhD
German Heart Center, Berlin, Germany
Shlomo Gabbay, MD
UMDNJ New Jersey Medical School, Newark
Thierry Carrel, MD
University Hospital, Berne, Switzerland